Evidence map›Paper›PMID 26997299›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2016

Novel Primate Model of Serotonin Transporter Genetic Polymorphisms Associated with Gene Expression, Anxiety and Sensitivity to Antidepressants.

Andrea M Santangelo, Mitsuteru Ito, Yoshiro Shiba, Hannah F Clarke, Evelien Hs Schut, Gemma Cockcroft, Anne C Ferguson-Smith, Angela C Roberts

Open access · hybridAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Resting-State fMRI-Based Screening of Deschloroclozapine in Rhesus Macaques Predicts Dosage-Dependent Behavioral Effects.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Trait Anxiety Mediated by Amygdala Serotonin Transporter in the Common Marmoset.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. The Neurobiology of Panic: A Chronic Stress Disorder.Chronic stress (Thousand Oaks, Calif.)
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Andrea M SantangeloDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Mitsuteru ItoDepartment of Genetics, University of Cambridge, Cambridge, UK.
Yoshiro ShibaDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.ORCID 0000-0002-4948-4646
Hannah F ClarkeDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Evelien Hs SchutBrain Center Rudolf Magnus, Department of Translational Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.
Gemma CockcroftDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Anne C Ferguson-SmithDepartment of Genetics, University of Cambridge, Cambridge, UK.
Angela C RobertsDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
University of Cambridge · GBUniversity Medical Center Utrecht · NL

Funding

Medical Research Council G0901884Medical Research Council G1000183Medical Research Council MR/M023990/1Wellcome Trust 093875Wellcome Trust 095606
6 · The paper itself

Abstract

Genetic polymorphisms in the repeat upstream region of the serotonin transporter gene (SLC6A4) are associated with individual differences in stress reactivity, vulnerability to affective disorders, and response to pharmacotherapy. However, the molecular, neurodevelopmental and psychopharmacological mechanisms underlying the link between SLC6A4 polymorphisms and the emotionally vulnerable phenotype are not fully understood. Thus, using the marmoset monkey Callithrix jacchus we characterize here a new neurobiological model to help to address these questions. We first sequenced the marmoset SLC6A4 promoter and identified a double nucleotide polymorphism (-2053AC/CT) and two single-nucleotide polymorphisms (-2022C/T and -1592G/C) within the repeat upstream region. We showed their association with gene expression using in vivo quantitative PCR and with affective behavior using a primate test of anxiety (human intruder test). The low-expressing haplotype (AC/C/G) was linked with high anxiety while the high-expressing one (CT/T/C) was associated with an active coping strategy in response to threat. Pharmacological challenge with an acute dose of the selective serotonin reuptake inhibitor, citalopram, revealed a genotype-dependent behavioral response. While individuals homozygous for the high anxiety-related haplotype AC/C/G exhibited a dose-dependent, anxiogenic response, individuals homozygous for the low anxiety-related haplotype CT/T/C showed an opposing, dose-dependent anxiolytic effect. These findings provide a novel genetic and behavioral primate model to study the molecular, neurodevelopmental, and psychopharmacological mechanisms that underlie genetic variation-associated complex behaviors, with specific implications for the understanding of normal and abnormal serotonin actions and the development of personalized pharmacological treatments for psychiatric disorders.

Indexed as

Disease Models, AnimalGene ExpressionPolymorphism, GeneticAdaptation, PsychologicalAnimalsAntidepressive Agents, Second-GenerationAnxietyBehavior, AnimalCallithrixFemaleGene Expression RegulationHaplotypesMaleSelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport ProteinsAntidepressive Agents, Second-GenerationSelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport Proteins

Identifiers

PMID26997299
PMCPMC4946067
OpenAlexW2306479064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.